Asset Details
Do you wish to reserve the book?
Tacrolimus reduces atherosclerotic plaque formation in ApoE.sup.-/- mice by inhibiting NLRP3 inflammatory corpuscles
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tacrolimus reduces atherosclerotic plaque formation in ApoE.sup.-/- mice by inhibiting NLRP3 inflammatory corpuscles
Do you wish to request the book?
Tacrolimus reduces atherosclerotic plaque formation in ApoE.sup.-/- mice by inhibiting NLRP3 inflammatory corpuscles
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tacrolimus reduces atherosclerotic plaque formation in ApoE.sup.-/- mice by inhibiting NLRP3 inflammatory corpuscles
2020
Overview
Effect of tacrolimus on atherosclerotic plaques and its influence on Nod-like receptor protein 3 (NLRP3) inflammatory pathway were studied by establishing the mouse model of atherosclerosis. The mice were divided into 3 groups: C57BL/6 mouse group (WT group), [ApoE.sup.-/-] mouse group ([ApoE.sup.-/-] group) and [ApoE.sup.-/-] mouse + tacrolimus intervention group ([ApoE.sup.-/-] + Tac group). The area of atherosclerotic plaques and the pathological morphologic changes were observed. The NLRP3, interleukin-1[beta] (IL-1[beta]), IL-18, NLRP3 inflammatory corpuscles, pro-inflammatory factors IL-1[beta] and IL-18 in the aorta were analyzed. The area of atherosclerotic plaques in [ApoE.sup.-/-] mice was increased significantly, and it was significantly reduced after tacrolimus intervention. After tacrolimus intervention, the arterial intima became obviously thinner and no obvious cholesterol crystals were observed. The macrophage infiltration in atherosclerotic plaques was significantly increased, and the content of smooth muscle cells was also increased. The levels of serum IL-1[beta], IL-18 and NLRP3 in [ApoE.sup.-/-] mice were significantly increased, and they remarkably declined after tacrolimus intervention. ROS content in atherosclerotic plaques was increased in [ApoE.sup.-/-] mice, and it remarkably declined after tacrolimus intervention. The protein content of NLRP3, ASC, Casp-1, IL-1[beta] and IL-18 in the aorta in [ApoE.sup.-/-] mice was remarkably increased, and they were inhibited to some extent after tacrolimus intervention. In conclusion, it is speculated that tacrolimus may reduce the formation of AS through inhibiting ROS in macrophages and activation of NLRP3 inflammatory corpuscles and reducing the release of IL-1[beta] and IL-18. Key words: tacrolimus, atherosclerosis, NLRP3, inflammation, ROS
Publisher
Spandidos Publications
Subject
We currently cannot retrieve any items related to this title. Kindly check back at a later time.